Advertisement

Ads Placeholder
Loading...

Notable Labs, Ltd.

NTBLNASDAQ
Healthcare
Biotechnology
$0.25
$-0.09(-27.68%)
U.S. Market opens in 21h 58m

Notable Labs, Ltd. Fundamental Analysis

Notable Labs, Ltd. (NTBL) shows weak financial fundamentals with a PE ratio of -0.05, profit margin of -36.34%, and ROE of -59.97%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position2129.67%
PEG Ratio-0.00
Current Ratio5.65

Areas of Concern

ROE-59.97%
Operating Margin-47.28%
We analyze NTBL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3457.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3457.1/100

We analyze NTBL's fundamental strength across five key dimensions:

Efficiency Score

Weak

NTBL struggles to generate sufficient returns from assets.

ROA > 10%
-57.64%

Valuation Score

Excellent

NTBL trades at attractive valuation levels.

PE < 25
-0.05
PEG Ratio < 2
-0.00

Growth Score

Weak

NTBL faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

NTBL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.14
Current Ratio > 1
5.65

Profitability Score

Weak

NTBL struggles to sustain strong margins.

ROE > 15%
-5997.07%
Net Margin ≥ 15%
-36.34%
Positive Free Cash Flow
No

Key Financial Metrics

Is NTBL Expensive or Cheap?

P/E Ratio

NTBL trades at -0.05 times earnings. This suggests potential undervaluation.

-0.05

PEG Ratio

When adjusting for growth, NTBL's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Notable Labs, Ltd. at 0.04 times its book value. This may indicate undervaluation.

0.04

EV/EBITDA

Enterprise value stands at -0.85 times EBITDA. This is generally considered low.

-0.85

How Well Does NTBL Make Money?

Net Profit Margin

For every $100 in sales, Notable Labs, Ltd. keeps $-36.34 as profit after all expenses.

-36.34%

Operating Margin

Core operations generate -47.28 in profit for every $100 in revenue, before interest and taxes.

-47.28%

ROE

Management delivers $-59.97 in profit for every $100 of shareholder equity.

-59.97%

ROA

Notable Labs, Ltd. generates $-57.64 in profit for every $100 in assets, demonstrating efficient asset deployment.

-57.64%

Following the Money - Real Cash Generation

Operating Cash Flow

Notable Labs, Ltd. generates limited operating cash flow of $-59.15M, signaling weaker underlying cash strength.

$-59.15M

Free Cash Flow

Notable Labs, Ltd. generates weak or negative free cash flow of $-59.43M, restricting financial flexibility.

$-59.43M

FCF Per Share

Each share generates $-6.15 in free cash annually.

$-6.15

FCF Yield

NTBL converts -5.76% of its market value into free cash.

-5.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.05

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.04

vs 25 benchmark

P/S Ratio

Price to sales ratio

7.72

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.14

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.65

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.60

vs 25 benchmark

ROA

Return on assets percentage

-0.58

vs 25 benchmark

ROCE

Return on capital employed

-0.87

vs 25 benchmark

How NTBL Stacks Against Its Sector Peers

MetricNTBL ValueSector AveragePerformance
P/E Ratio-0.0528.45 Better (Cheaper)
ROE-59.97%763.00% Weak
Net Margin-3633.55%-45265.00% (disorted) Weak
Debt/Equity0.140.34 Strong (Low Leverage)
Current Ratio5.652795.60 Strong Liquidity
ROA-57.64%-16588.00% (disorted) Weak

NTBL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Notable Labs, Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ